Kolkata: Bengal Chemicals and Pharmaceutical Company has received the license to produce Hydroxychloroquine, an anti-malarial drug that is being touted as “game changer” in the fight against COVID-19 pandemic, a top company official said.
The Drug Controller General of India has allowed Bengal Chemicals to produce 200 mg and 400 mg Hydroxychloroquine tablets, company Managing Director PM Chandraiah said on Friday.
“We are ready to do the formulation without any profit as a gesture to fight COVID-19,” news agency PTI quoted Chandraiah as saying.
The company can produce 10 lakh tablets a day and can ramp it up to 15 lakhs, he said.
“But, the question is raw material. The government has to arrange raw materials or active pharmaceutical ingredients (API). We have failed to arrange it from our end,” he added.
Dubai: ODI cricket, Pakistan – they bring out the best in Virat Kohli. The Dubai… Read More
Cuttack: Three criminals were arrested by Choudwar police in Odisha’s Cuttack district for allegedly looting… Read More
Kolkata: Odisha FC fought gallantly in the lion’s den but finally returned empty-handed. Up against league… Read More
Kolkata: A West Bengal secondary board exam (Madhyamik) candidate recently took Artificial Intelligence (AI) to… Read More
New Delhi: A fourth batch of Indian nationals deported from the US arrived at Indira… Read More
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
This website uses cookies.
